サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1451657

コンパニオンアニマルヘルス市場レポート：動物タイプ、製品、エンドユーザー、地域別、2024-2032

Companion Animal Health Market Report by Animal Type, Product, End User, and Region 2024-2032
出版日: | 発行: IMARC | ページ情報: 英文 139 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
コンパニオンアニマルヘルス市場レポート：動物タイプ、製品、エンドユーザー、地域別、2024-2032
出版日: 2024年03月02日
発行: IMARC
ページ情報: 英文 139 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のコンパニオンアニマルヘルス市場規模は2023年に254億米ドルに達しました。今後、IMARC Groupは、2024年から2032年の間に7.7%の成長率（CAGR）を示し、市場は2032年までに505億米ドルに達すると予測しています。世界のペット飼育率の上昇、獣医学ヘルスケアの継続的な進歩、動物由来感染症に対する意識の高まりが、動物用医薬品とサービスの需要増につながっていることが、市場を推進している主な要因の一部です。

コンパニオンアニマルヘルス市場の分析：

市場の成長と規模ペットの飼育動向の上昇とペットの健康に対する意識の高まりにより、市場は現在大きな成長を遂げています。この市場には、医薬品、ワクチン、診断薬、飼料添加物など、ペットの健康ニーズに応える幅広い製品とサービスが含まれています。

主な市場促進要因：主な促進要因としては、ペットの飼育率の増加、獣医学ヘルスケアの進歩、人獣共通感染症への関心の高まりなどが挙げられます。これらの要因により、様々な動物用医薬品やサービスに対する需要が高まっています。

技術の進歩：技術革新、特に診断と治療オプションが市場の成長を促進しています。遠隔医療や健康アプリなどのデジタル技術の統合は、動物医療のアクセシビリティと効率を高めています。

産業用途：同市場は、コンパニオンアニマルの予防ケア、疾病治療、栄養管理、慢性状態モニタリングに応用されています。動物病院や診療所、家庭内検査も主要な応用分野です。

主な市場動向：主な動向としては、予防ヘルスケア重視の高まり、ペット保険の台頭、個別化されたペットケアソリューションへの嗜好の高まりなどが挙げられます。また、より自然でオーガニックなペット用健康製品へのシフトも見られます。

地理的動向：北米が市場をリードし、アジア太平洋地域はライフスタイルの変化と経済開発により急成長を示しています。また、欧州はペットケアの水準が高く、規制の枠組みも整っているため、市場で強い存在感を示しています。

競合情勢：市場の特徴は、研究開発、戦略的提携、製品ポートフォリオの拡充に取り組む大手企業が複数存在することです。競合は製品の革新性、品質、ブランドの評判に基づいています。

課題と機会：課題には、規制のハードル、動物医療費の高騰、地域による高度医療へのアクセスの格差などがあります。しかし、新興国市場、費用対効果の高い製品の開拓、遠隔医療サービスに対する需要の高まりなどには多くの機会があります。

将来の展望：コンパニオンアニマルヘルス産業は、高度ヘルスケアソリューション、個別化医療、持続可能な診療への注目の高まりとともに、成長軌道を継続すると予想されます。この市場は、継続的な技術革新と動物福祉重視の高まりから恩恵を受ける可能性が高いです。

コンパニオンアニマルヘルス市場の動向：

ペット飼育率の増加

コンパニオンアニマルヘルス市場は現在、世界のペット飼育率の上昇により大きな成長を遂げています。これは、ペットがますます家族の一員とみなされるようになった社会規範の変化に大きく起因しています。このようなペットとの情緒的な結びつきが、ペットの健康と福祉への関心の高まりにつながり、さまざまな動物用医薬品やサービスの需要を促進しています。都市化、消費者の可処分所得の増加、動物の健康に対する意識の高まりといった動向も、この傾向に拍車をかけています。ペットの飼い主はより多くの情報を得るようになり、ペットのためにより良いヘルスケア、栄養、ウェルネス製品を求めるようになり、それがコンパニオンアニマルヘルス市場の成長に拍車をかけています。

動物医療の進歩

同市場はまた、動物用ヘルスケアにおける継続的な進歩によっても後押しされています。これらの進歩は、診断学、治療学、予防医療を含む幅広い分野に及んでいます。さらに、新しいワクチン、医薬品、診断ツールの開発は、さまざまな動物の病気のより効果的かつ効率的な治療を可能にしています。遠隔医療やモバイル・ヘルス・アプリケーションなど、獣医診療における技術の統合もまた、重要な役割を果たしています。これらの技術革新は、コンパニオンアニマルに提供されるケアの質を向上させ、ペットの飼い主のための獣医サービスのアクセシビリティと利便性を高める。この要素は、ペットのためにタイムリーで効果的なヘルスケアソリューションを提供する能力に直接影響するため、コンパニオンアニマルヘルス市場の成長を増強する上で極めて重要です。

人獣共通感染症への関心の高まり

人畜共通感染症（動物から人へ感染する病気）に対する認識と懸念の高まりは、コンパニオンアニマルヘルス市場を刺激するもう一つの重要な要因です。特に最近のコロナウイルス（COVID-19）の大流行は、人畜共通感染症がもたらす潜在的なリスクに対する意識の高まりにつながっています。その結果、コンパニオンアニマルにおけるこのような疾病のモニタリングと予防に重点が置かれるようになった。この動向は、人獣共通感染症の病原体を標的としたワクチンや治療法の研究開発（R&D）への多額の投資を促進しています。これに加えて、世界中の規制機関や動物保健団体は、厳しいガイドラインや予防措置の確立により重点を置くようになり、その結果、動物用医薬品やサービスの需要を喚起しています。人畜共通感染症の予防に対するこのような関心の高まりは、公衆衛生にとって極めて重要であると同時に、コンパニオンアニマルヘルス市場の成長を支えるものでもあります。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 コンパニオンアニマルヘルスの世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：動物タイプ別

  • 犬
    • 市場動向
    • 市場予測
  • 猫
    • 市場動向
    • 市場予測
  • 馬
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第7章 市場内訳：製品別

  • ワクチン
    • 市場動向
    • 市場予測
  • 医薬品
    • 市場動向
    • 市場予測
  • 飼料添加物
    • 市場動向
    • 市場予測
  • 診断
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：エンドユーザー別

  • ポイントオブケア/院内検査
    • 市場動向
    • 市場予測
  • 動物病院・クリニック
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Agrolabo S.p.A.
    • Boehringer Ingelheim
    • Ceva Sante Animale
    • Dechra Pharmaceuticals PLC
    • Elanco Animal Health Incorporated
    • IDEXX Laboratories Inc.
    • Indian Immunologicals Limited（National Dairy Development Board）
    • Merck & Co. Inc.
    • Norbrook Laboratories
    • Vetoquinol SA
    • Virbac
    • Zoetis Inc.
図表

List of Figures

  • Figure 1: Global: Companion Animal Health Market: Major Drivers and Challenges
  • Figure 2: Global: Companion Animal Health Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Companion Animal Health Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Companion Animal Health Market: Breakup by Animal Type (in %), 2023
  • Figure 5: Global: Companion Animal Health Market: Breakup by Product (in %), 2023
  • Figure 6: Global: Companion Animal Health Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Companion Animal Health Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Companion Animal Health (Dogs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Companion Animal Health (Dogs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Companion Animal Health (Cats) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Companion Animal Health (Cats) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Companion Animal Health (Equine) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Companion Animal Health (Equine) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Companion Animal Health (Other Animal Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Companion Animal Health (Other Animal Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Companion Animal Health (Vaccines) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Companion Animal Health (Vaccines) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Companion Animal Health (Pharmaceuticals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Companion Animal Health (Pharmaceuticals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Companion Animal Health (Feed Additives) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Companion Animal Health (Feed Additives) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Companion Animal Health (Diagnostics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Companion Animal Health (Diagnostics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Companion Animal Health (Other Products) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Companion Animal Health (Other Products) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Companion Animal Health (Point-of-care Testing/In-house Testing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Companion Animal Health (Point-of-care Testing/In-house Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Companion Animal Health (Veterinary Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Companion Animal Health (Veterinary Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Companion Animal Health (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Companion Animal Health (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: North America: Companion Animal Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: North America: Companion Animal Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: United States: Companion Animal Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: United States: Companion Animal Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Canada: Companion Animal Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Canada: Companion Animal Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Asia-Pacific: Companion Animal Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Asia-Pacific: Companion Animal Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: China: Companion Animal Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: China: Companion Animal Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Japan: Companion Animal Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Japan: Companion Animal Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: India: Companion Animal Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: India: Companion Animal Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: South Korea: Companion Animal Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: South Korea: Companion Animal Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Australia: Companion Animal Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Australia: Companion Animal Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Indonesia: Companion Animal Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Indonesia: Companion Animal Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Others: Companion Animal Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Others: Companion Animal Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Europe: Companion Animal Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Europe: Companion Animal Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Germany: Companion Animal Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Germany: Companion Animal Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: France: Companion Animal Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: France: Companion Animal Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: United Kingdom: Companion Animal Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: United Kingdom: Companion Animal Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Italy: Companion Animal Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Italy: Companion Animal Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Spain: Companion Animal Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Spain: Companion Animal Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Russia: Companion Animal Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Russia: Companion Animal Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Others: Companion Animal Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Others: Companion Animal Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Latin America: Companion Animal Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Latin America: Companion Animal Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Brazil: Companion Animal Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Brazil: Companion Animal Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Mexico: Companion Animal Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Mexico: Companion Animal Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Others: Companion Animal Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Others: Companion Animal Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Middle East and Africa: Companion Animal Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Middle East and Africa: Companion Animal Health Market: Breakup by Country (in %), 2023
  • Figure 80: Middle East and Africa: Companion Animal Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Global: Companion Animal Health Industry: SWOT Analysis
  • Figure 82: Global: Companion Animal Health Industry: Value Chain Analysis
  • Figure 83: Global: Companion Animal Health Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Companion Animal Health Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Companion Animal Health Market Forecast: Breakup by Animal Type (in Million US$), 2024-2032
  • Table 3: Global: Companion Animal Health Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 4: Global: Companion Animal Health Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Companion Animal Health Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Companion Animal Health Market: Competitive Structure
  • Table 7: Global: Companion Animal Health Market: Key Players
目次
Product Code: SR112024A5482

The global companion animal health market size reached US$ 25.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 50.5 Billion by 2032, exhibiting a growth rate (CAGR) of 7.7% during 2024-2032. The rising pet ownership rates worldwide, continuous advancements in veterinary healthcare, and heightened awareness of zoonotic diseases, leading to increased demand for animal health products and services, are some of the major factors propelling the market.

Companion Animal Health Market Analysis:

Market Growth and Size: The market is currently experiencing significant growth, driven by the rising trend of pet ownership and heightened awareness about pet health. This market encompasses a wide range of products and services, including pharmaceuticals, vaccines, diagnostics, and feed additives, catering to the health needs of pets.

Major Market Drivers: Key drivers include the increasing rates of pet ownership, advancements in veterinary healthcare, and a growing focus on zoonotic diseases. These factors are leading to a higher demand for various animal health products and services.

Technological Advancements: Technological innovations, particularly in diagnostics and treatment options, are propelling the market growth. The integration of digital technologies, such as telemedicine and health apps, is enhancing the accessibility and efficiency of veterinary care.

Industry Applications: The market finds its applications in preventive care, treatment of diseases, nutritional management, and chronic condition monitoring in companion animals. Veterinary hospitals and clinics, along with in-home testing, are other key application areas.

Key Market Trends: Major trends include the increasing emphasis on preventive healthcare, the rise of pet insurance, and the growing preference for personalized pet care solutions. The market is also seeing a shift toward more natural and organic pet health products.

Geographical Trends: North America leads the market, while the Asia Pacific region shows rapid growth due to changing lifestyles and economic development. Europe also maintains a strong market presence with its high standards of pet care and regulatory framework.

Competitive Landscape: The market is characterized by the presence of several leading players engaging in research and development (R&D), strategic alliances, and expansion of product portfolios. Competition is based on product innovation, quality, and brand reputation.

Challenges and Opportunities: Challenges include regulatory hurdles, high costs of veterinary care, and disparities in access to advanced healthcare in different regions. However, numerous opportunities lie in emerging markets, the development of cost-effective products, and the escalating demand for telehealth services.

Future Outlook: The companion animal health industry is expected to continue its growth trajectory, with a heightened focus on advanced healthcare solutions, personalized medicine, and sustainable practices. This market is likely to benefit from ongoing technological innovations and a growing emphasis on animal welfare.

Companion Animal Health Market Trends:

Increasing Pet Ownership Rates

The companion animal health market is currently witnessing significant growth due to the rising rates of pet ownership globally. This can be largely attributed to changing societal norms where pets are increasingly considered as part of the family. This emotional bonding with pets is leading to a greater focus on their health and well-being, thereby driving demand for various animal health products and services. Factors such as urbanization, inflating consumer disposable incomes, and the growing awareness of animal health are further contributing to this trend. As pet owners are becoming more informed, they are seeking better healthcare, nutrition, and wellness products for their pets, which, in turn, is fueling the growth of the companion animal health market.

Advancements in Veterinary Healthcare

The market is also being propelled by the ongoing advancements in veterinary healthcare. These advancements encompass a wide range of areas, including diagnostics, therapeutics, and preventive care. Moreover, the development of new vaccines, pharmaceuticals, and diagnostic tools is enabling more effective and efficient treatment of various animal diseases. The integration of technology in veterinary practices, such as telemedicine and mobile health applications, is also playing a crucial role. These technological innovations improve the quality of care provided to companion animals and enhance the accessibility and convenience of veterinary services for pet owners. This factor is crucial in augmenting the growth of the companion animal health market as it directly impacts the ability to provide timely and effective healthcare solutions for pets.

Growing Focus on Zoonotic Diseases

The growing awareness and concern regarding zoonotic diseases - illnesses that can be transmitted from animals to humans - is another significant factor stimulating the companion animal health market. The recent coronavirus (COVID-19) pandemic has particularly led to a heightened awareness about the potential risks posed by zoonotic diseases. As a result, there is an increased emphasis on monitoring and preventing such diseases in companion animals. This trend is fostering substantial investments in research and development (R&D) of vaccines and treatments that target zoonotic pathogens. Besides this, regulatory bodies and animal health organizations worldwide are now more focused on establishing stringent guidelines and preventive measures, which in turn are catalyzing the demand for animal health products and services. This rising focus on preventing zoonotic diseases is crucial for public health as well as instrumental in supporting the growth of the companion animal health market.

Companion Animal Health Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on animal type, product, and end user.

Breakup by Animal Type:

Dogs

Cats

Equine

Others

Dogs account for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the animal type. This includes dogs, cats, equine, and others. According to the report, dogs represented the largest segment.

The dogs segment holds the largest share in the companion animal health market, reflecting the widespread ownership of dogs as pets globally. This segment benefits from the strong emotional bond between dogs and their owners, leading to considerable spending on healthcare, nutrition, and wellness products. Dog owners are increasingly seeking preventive healthcare, regular check-ups, and advanced treatments for their pets, driving demand for a range of products from pharmaceuticals to specialized diets. Innovations in dog healthcare, including advanced therapeutics and diagnostics, are also key factors contributing to the growth of this segment. The market for dogs is further strengthened by the rising trend of pet humanization, where owners treat their dogs as family members, ensuring high-quality healthcare and lifestyle products.

The cats segment in the companion animal health market is significant, fueled by the growing popularity of cats as pets, especially in urban settings. Cat owners are becoming more attentive to their pets' health needs, leading to increased demand for cat-specific healthcare products and services. This segment is experiencing growth in areas such as routine health check-ups, vaccinations, and chronic disease management. Additionally, there is a rising interest in specialized nutrition and wellness products tailored for cats, including age-specific and breed-specific formulations. The market is also witnessing a widespread adoption of advanced diagnostic and treatment options for cats, reflecting the growing concern for their well-being among pet owners.

The equine segment, though smaller compared to dogs and cats, plays a vital role in the market. This segment caters to the health and wellness needs of horses, with a focus on both preventive care and treatment of illnesses. The market is driven by the needs of professional breeders, equestrian sports enthusiasts, and individual horse owners. There is a significant demand for vaccinations, parasite control products, and nutritional supplements specific to horses. Additionally, the segment is seeing advancements in diagnostic and treatment technologies, including imaging and surgical procedures tailored for equine health. The rising interest in equestrian sports and recreational horse riding also contributes to the steady growth of this segment.

Breakup by Product:

Vaccines

Pharmaceuticals

Feed Additives

Diagnostics

Others

A detailed breakup and analysis of the market based on the product have also been provided in the report. This includes vaccines, pharmaceuticals, feed additives, diagnostics, and others.

Vaccines play a vital role in preventing various infectious diseases in pets. This segment is driven by increasing awareness about the importance of regular vaccinations for pets, along with the development of new and more effective vaccines. Innovations in vaccine technology, such as recombinant vaccines and DNA vaccines, are enhancing the efficacy and safety profiles of these products. The demand for vaccines is also being strengthened by stringent regulations and recommendations by veterinary bodies, emphasizing the necessity of vaccinations as a part of preventive healthcare for companion animals.

The pharmaceuticals segment is a major component of the companion animal health market, encompassing a wide range of products, including anti-infectives, anti-inflammatories, and medicines for chronic conditions. This segment is expanding owing to the increasing prevalence of numerous health issues in pets, such as arthritis, diabetes, and heart disease. The development of new and more effective drugs, along with the growing trend of personalized medicine, is further driving this segment. Moreover, the rise in pet insurance and veterinary care spending is enabling pet owners to afford these pharmaceutical treatments, thereby contributing to the growth of this segment.

Feed additives play a significant role in the companion animal health market, focusing on improving the nutrition and overall health of pets. This segment includes a range of products like vitamins, minerals, amino acids, and probiotics, which are essential for the proper growth, development, and health maintenance of companion animals. The escalating demand for premium and specialized pet foods, coupled with the heightened understanding of the importance of nutrition in animal health, is fostering the growth of this segment. Additionally, the development of new and innovative feed additives that cater to specific health needs, such as digestive health or immune support, is further enhancing the market potential.

The diagnostics segment in the companion animal health market is gaining momentum, propelled by the increasing adoption of advanced diagnostic methods for accurate and early detection of diseases in pets. This segment includes a variety of diagnostic tools and services, such as blood tests, imaging, and molecular diagnostics. The growth in this segment is catalyzed by technological advancements, which are making diagnostics more accessible and cost-effective. Pet owners' growing preference for preventive healthcare measures, coupled with the need for regular health monitoring of aging pets, is also accelerating the expansion of this market segment. The integration of digital technologies, such as telemedicine, is further facilitating the growth and reach of diagnostic services in the companion animal health sphere.

Breakup by End User:

Point-of-Care Testing/In-House Testing

Veterinary Hospitals and Clinics

Others

Veterinary hospitals and clinics represent the leading market segment

The report has provided a detailed breakup and analysis of the market based on the end user. This includes point-of-care testing/in-house testing, veterinary hospitals and clinics, and others. According to the report, veterinary hospitals and clinics represented the largest segment.

Veterinary hospitals and clinics serve as the primary care providers for companion animals. This segment includes a comprehensive range of services, from routine check-ups and vaccinations to advanced surgical procedures and emergency care. The dominance of this segment is attributed to the comprehensive care these facilities provide, backed by skilled veterinary professionals and advanced medical technologies. Veterinary hospitals and clinics are essential for diagnosing and treating more complex health conditions in pets, which cannot be addressed through in-house testing alone. The rising focus on preventive healthcare, along with the increasing prevalence of various animal diseases and conditions, continues to drive pet owners to seek professional veterinary services, thereby sustaining the growth and significance of this market segment.

The point-of-care testing (POCT) or in-house testing segment in the companion animal health market caters to the growing demand for convenient and rapid diagnostic testing. This segment includes a range of diagnostic tools and kits used by pet owners or veterinarians at home or in non-laboratory settings. The growth in this segment is supported by the increasing preference for immediate results and the convenience of conducting tests without the need for specialized equipment or external laboratory services. Technological advancements have led to the development of more accurate and user-friendly testing kits, making in-house testing a viable option for routine health monitoring and disease screening in pets. This segment is particularly appealing to pet owners who seek proactive management of their pets' health, offering an efficient way to monitor chronic conditions or perform regular health check-ups.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America leads the market, accounting for the largest companion animal health market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America held the biggest market share due to high pet ownership rates, substantial spending on pet care, and the presence of advanced veterinary healthcare infrastructure. This region is characterized by a strong emphasis on preventive care and wellness for pets, fueling the demand for a wide range of products and services, from vaccines to diagnostic tools. Additionally, the presence of major market players and continuous investment in research and development (R&D) in this region contribute to its leading position. The emerging trend of pet humanization, where pets are treated as family members, further propels the growth of the market in North America.

The Asia Pacific region is also experiencing rapid growth in the companion animal health market, driven by increasing pet ownership, rising disposable incomes, and heightened awareness of pet health and wellness. Urbanization and changing lifestyles are leading to a greater adoption of pets, particularly in emerging economies. The region is witnessing an increase in demand for quality veterinary services and healthcare products. Additionally, the expansion of veterinary healthcare facilities and the entry of international players into these markets are contributing to the growth of the market in the Asia Pacific region.

Europe holds a significant share of the companion animal health market, supported by high standards of pet care, well-established veterinary healthcare systems, and stringent animal health regulations. The market in this region is propelled by a strong focus on preventive care, advanced diagnostics, and treatment options. European pet owners are typically well-informed and willing to invest in the health and well-being of their pets, further supporting market growth. Moreover, Europe's strong regulatory framework ensures the availability of high-quality and safe animal health products, contributing to the growth of the market in this region.

The companion animal health market in Latin America is growing steadily, with an increasing number of households owning pets and a heightened awareness of pet health needs. The market is expanding owing to the gradual improvement in veterinary healthcare infrastructure and services. Economic growth in various countries in this region is enabling pet owners to spend more on pet care, including preventive and therapeutic products. However, the market still faces challenges, such as limited access to advanced veterinary care in some areas, which influences the overall growth potential of this segment.

The Middle East & Africa region, though smaller compared to other segments, is gradually emerging in the companion animal health market. This growth is attributed to increasing pet ownership in urban areas and rising awareness of pet health and welfare. The market is also benefiting from the growing investment in veterinary services and infrastructure. However, the region faces unique challenges, such as varying levels of economic development and cultural attitudes toward pet ownership, which impact the market dynamics. Nonetheless, the increasing focus on animal health and welfare in these regions offers potential for growth in the companion animal health sector.

Leading Key Players in the Companion Animal Health Industry:

Numerous key players in the companion animal health market are actively engaging in research and development (R&D) to innovate new products and services, focusing on areas like advanced therapeutics, diagnostics, and preventive care. They are also expanding their global reach through strategic partnerships, mergers, and acquisitions, aiming to enhance their product portfolios and market presence. Additionally, these companies are investing in digital technologies, such as telemedicine and mobile applications, to improve accessibility and efficiency in veterinary care. Emphasizing customer education and awareness programs, they aim to increase the understanding of pet health needs, thereby driving market growth and customer loyalty.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Agrolabo S.p.A.

Boehringer Ingelheim

Ceva Sante Animale

Dechra Pharmaceuticals PLC

Elanco Animal Health Incorporated

IDEXX Laboratories Inc.

Indian Immunologicals Limited (National Dairy Development Board)

Merck & Co. Inc.

Norbrook Laboratories

Vetoquinol SA

Virbac

Zoetis Inc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Latest News:

In September 2023, Ceva Sante Animale (Ceva), the global animal health company, announced the launch of its highly anticipated 2024 "Call for Projects". This worldwide event aims to discover and support new, innovative solutions for the well-being and care of companion animals and their pet parents.

In October 2023, Zoetis announced the U.S. commercial launch of Librela (bedinvetmab injection), demonstrating the company's advanced leadership in canine innovation and dedication to providing individualized care to address the health needs of dogs. Librela was approved by the U.S. Food and Drug Administration (FDA) on May 5, 2023, as a once-monthly injectable monoclonal antibody for the control of pain associated with osteoarthritis (OA) in dogs, helping to improve the mobility and quality of life for dogs with OA pain.

Key Questions Answered in This Report

  • 1. What was the size of the global companion animal health market in 2023?
  • 2. What is the expected growth rate of the global companion animal health market during 2024-2032?
  • 3. What has been the impact of COVID-19 on the global companion animal health market?
  • 4. What are the key factors driving the global companion animal health market?
  • 5. What is the breakup of the global companion animal health market based on the animal type?
  • 6. What is the breakup of the global companion animal health market based on the end user?
  • 7. What are the key regions in the global companion animal health market?
  • 8. Who are the key players/companies in the global companion animal health market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Companion Animal Health Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Animal Type

  • 6.1 Dogs
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Cats
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Equine
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Product

  • 7.1 Vaccines
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Pharmaceuticals
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Feed Additives
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Diagnostics
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Point-of-care Testing/In-house Testing
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Veterinary Hospitals and Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Agrolabo S.p.A.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Boehringer Ingelheim
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Ceva Sante Animale
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Dechra Pharmaceuticals PLC
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Elanco Animal Health Incorporated
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
    • 14.3.6 IDEXX Laboratories Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Indian Immunologicals Limited (National Dairy Development Board)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Merck & Co. Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Norbrook Laboratories
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Vetoquinol SA
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
    • 14.3.11 Virbac
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Zoetis Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis